A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

MLA

Riegersperger, Markus, et al. “A Non-Randomized Trial of Conversion from Ciclosporin and Tacrolimus to Tacrolimus MR4 in Stable Long-Term Kidney Transplant Recipients: Graft Function and Influences of ABCB1 Genotypes.” PloS One, vol. 14, no. 7, July 2019, p. e0218709. EBSCOhost, https://doi.org/10.1371/journal.pone.0218709.

APA

Riegersperger, M., Plischke, M., Jallitsch-Halper, A., Steinhauser, C., Födinger, M., Winkelmayer, W. C., Dunkler, D., & Sunder-Plassmann, G. (2019). A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes. PloS One, 14(7), e0218709. https://doi.org/10.1371/journal.pone.0218709

Chicago

Riegersperger, Markus, Max Plischke, Anita Jallitsch-Halper, Corinna Steinhauser, Manuela Födinger, Wolfgang C Winkelmayer, Daniela Dunkler, and Gere Sunder-Plassmann. 2019. “A Non-Randomized Trial of Conversion from Ciclosporin and Tacrolimus to Tacrolimus MR4 in Stable Long-Term Kidney Transplant Recipients: Graft Function and Influences of ABCB1 Genotypes.” PloS One 14 (7): e0218709. doi:10.1371/journal.pone.0218709.